Loss of wild type KRAS in KRASMUT lung adenocarcinoma is associated with cancer mortality and confers sensitivity to FASN inhibitors

Autor: Liu, Yan, Gao, Galen F., Minna, John D., Williams, Noelle S., Westover, Kenneth D. *
Zdroj: In Lung Cancer March 2021 153:73-80
Databáze: ScienceDirect